Former Practice Fusion Sales Executive, Steven Mack Pleads Guilty To Obstructing Government Investigations Into Purdue Pharma And Practice Fusion
(STL.News) Today Steven Mack, 46, of Bridgeville, Pennsylvania, pleaded guilty before Judge William K. Sessions III of the United States District Court for the District of Vermont to one count of attempting to obstruct a federal investigation into the relationship between Mr. Mack’s former employer, Practice Fusion, Inc., and Purdue Pharma LP, the seller of extended release opioid products, including OxyContin.
As explained during the plea hearing, in 2015 and 2016 Mr. Mack was the Director of National Accounts for Practice Fusion, an electronic medical record (EMR) company. In that position, Mr. Mack was a principal point of contact between Practice Fusion and Purdue Pharma with regard to the subject of the investigations. Mr. Mack admitted deleting from his company-issued laptop hundreds of computer files relevant to the investigation, with the intent to obstruct the investigation by impairing the integrity and availability of those records.
Pursuant to the plea agreement, Mr. Mack has agreed to cooperate with respect to ongoing investigations and to provide information about all criminal activities known to Mr. Mack. Pursuant to the plea agreement, which still must be accepted by Judge Sessions, Mr.